In vivo delayed rejection of tumors and inhibition of delayed - type hypersensitivity by HT-29 human colonic adenocarcinoma cell line

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00205634PMID 3594485PMCID PMC11038160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancement of production of superoxide anion by human monocytes exposed to products of ht 29 human colonic adenocarcinoma cell line

  1987cited by this paper
• Enhancement of production of superoxide anion by human polymorphonuclear leukocytes exposed to products of the HT-29 human colonic adenocarcinoma cell line.

  1986cited by this paper
• Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia.

  1986cited by this paper
• Immunomodulating activities associated with the cytosol fraction of a 3-methylcholanthrene-induced rat fibrosarcoma--II. Association with polyamine complexes.

  1986cited by this paper
• Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

  1985cited by this paper
• Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations.

  1984cited by this paper
• The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.

  1984cited by this paper
• Soluble suppressor factors elaborated in experimental malignant ascites.

  1984cited by this paper
• The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA‐DR antigens on the tumor cells

  1984cited by this paper
• Immunomodulating activities associated with the cytosol fraction of a 3-methylcholanthrene-induced rat fibrosarcoma.

  1984cited by this paper
• Modulation of anti‐tumour immunity induced by syngeneic mitomycin C‐treated murine tumour cells

  1984influential reference
• Immunosuppressive Factors Produced by Tumors and Their Effects on the RES

  1983cited by this paper
• Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

  1983cited by this paper
• Tumor induced immunosuppression.

  1983cited by this paper
• Immunoregulatory factors derived from human tumors. II. Partial purification and further immunobiochemical characterization of a human sarcoma-derived immunosuppressive factor expressing HLA-DR and immunoglobulin-related determinants.

  1983cited by this paper
• Regulation of human lymphocyte-mediated natural killer (NK) cell activity. I. Inhibition in vitro by peripheral blood granulocytes.

  1983cited by this paper
• Purification and functional characterization of a low molecular weight immune modulating factor produced by lewis lung carcinoma

  1982cited by this paper
• Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.

  1982cited by this paper
• Polyamines in mammalian tumors. Part II.

  1982cited by this paper
• Murine alveolar macrophage-mediated lymphocyte cytostasis: kinetics and mechanisms.

  1982cited by this paper
• Immunosuppression associated with SJL/J murine lymphoma. II. Characterization of a plasma suppressor factor in tumor-bearing mice.

  1981cited by this paper
• Correlation between immunosuppressive agents from media of human malignant melanoma cell cultures and from human serum.

  1981cited by this paper
• Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid

  1981cited by this paper
• Polyamines in mammalian tumors. Part I.

  1981cited by this paper
• Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

  1981cited by this paper
• Nonspecific inhibitory activity of soluble human colon carcinoma extracts: tentative mechanism of action.

  1981cited by this paper
• Explant culture of human colon.

  1980cited by this paper
• Characterization of an inhibitor of cell division released in tumour cell cultures.

  1980cited by this paper
• Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation.

  1980cited by this paper
• An inhibitor of lymphocyte proliferation produced by a human colonic adenocarcinoma cell line in culture.

  1980cited by this paper
• Inhibition of lymphocyte growth by spermidine in medium containing fetal bovine serum

  1980cited by this paper
• Immunosuppressive factors from mastocytoma cells cultured in serum-free medium.

  1980cited by this paper
• Immunologic reactivity of lymphoid cells in tumors.

  1980cited by this paper
• Chapter 19 Explant Culture of Human Colon

  1980cited by this paper
• Dynamic state of spontaneous immune reactivity towards a mammary adenocarcinoma

  1979cited by this paper
• Inhibition of lymphocyte proliferation by polyamines requires ruminant-plasma polyamine oxidase.

  1979influential reference
• Explant culture of human colon.

  1978cited by this paper
• Polyamines in rapid growth and cancer.

  1978cited by this paper
• Nonspecific suppressive and cytostatic activities mediated by human colonic carcinoma tissue or cultured cell extract.

  1978cited by this paper
• Macrophages and resistance to tumors

  1978cited by this paper
• Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.

  1978cited by this paper
• Immunosuppression and the role of suppressive factors in cancer.

  1977cited by this paper
• [Immunochemical study of liver metastases of colonic tumors].

  1975cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Combination of interferons and cytostatic drugs for treatment of advanced colorectal cancer

  2005cites this paper
• "Multi-enzyme-targeted" immunochemotherapy: a salvage therapy protocol.

  1999cites this paper
• Ascitic growth of a T cell lymphoma in mice alters the humoral and cellular immune response to exogenous antigens.

  1997cites this paper
• Nitric oxide involvement in tumor-induced immunosuppression.

  1994cites this paper
• Immunomodulation by soluble factors from tumor cells cultured in vivo in diffusion chambers.

  1994cites this paper
• Inhibition of proliferation, activation and function of human natural-killer-cells in-vitro by secreted products of lovo, a colorectal-cancer cell-line.

  1993cites this paper
• Immunosuppressive factors in human cancer.

  1993cites this paper
• Inhibition of interleukin-2 dependent immune responses by serum from patients with advanced gastrointestinal cancer.

  1993cites this paper
• [Chemo- and immunotherapy of colorectal cancer].

  1991cites this paper
• Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines.

  1989cites this paper